心力衰竭合并心房颤动的治疗策略选择  

Choice of treatment strategies for heart failure combined with atrial fibrillation

作　　者：王传合[1] 孙志军[1] 李晓东[1] WANG Chuan-he;SUN Zhi-jun;LI Xiao-dong(Department of Cardiology,Shengjing Hospital Affiliated to China Medical University,Shenyang 110022,China)

机构地区：[1]中国医科大学附属盛京医院心内科,辽宁沈阳110022

出　　处：《中国实用内科杂志》2020年第12期996-1000,共5页Chinese Journal of Practical Internal Medicine

基　　金：辽宁省科学技术计划项目(2018225003)。

摘　　要：心力衰竭(简称心衰)和心房颤动(简称房颤)是21世纪最难攻克的两大心血管疾病,二者常互为因果,形成恶性循环,并发心衰和房颤的患者临床表现更为严重,预后更差。中国心衰注册研究显示,住院心衰患者中房颤发生率高达24.4%,房颤的发生率与纽约心功能分级(NYHA)相关,分级加重时房颤患病率上升。心衰合并房颤患者的治疗一直是学术界研究的热点之一,目前的基本治疗策略是心室率控制、节律控制及血栓预防治疗。文章对心衰合并房颤治疗策略的最新进展作一简要评述。In the 21 st century,the two cardiovascular diseases most difficult to conquer are heart failure(HF)and atrial fibrillation(AF),which interact as both cause and effect,forming a vicious circle. Patients with complicated heart failure and atrial fibrillation suffer from more severe clinical manifestations and worse prognosis. The Chinese Heart Failure Registry study shows that the incidence of atrial fibrillation in inpatients with heart failure is as high as 24.4%. The incidence of atrial fibrillation is related to the New York Heart Function Classification(NYHA),the more aggravated the classification is,the higher the incidence of atrial fibrillation. The therapy for patients with heart failure combined with atrial fibrillation has been one of the hot spots in the academic research. The current basic treatment strategies are heart rate control,rhythm control and thromboprophylaxis. Here,the latest development of therapy strategies is reviewed.

关 键 词：心房颤动 心力衰竭 导管消融 希蒲系统起搏 

分 类 号：R541[医药卫生—心血管疾病]